{"title":"注:miR-1294表达下调,预示胃癌预后不良。","authors":"Y-X Shi, B-L Ye, B-R Hu, X-J Ruan","doi":"10.26355/eurrev_202603_37717","DOIUrl":null,"url":null,"abstract":"<p><p>The article \"Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer\" by Y.-X. Shi, B.-L. Ye, B.-R. Hu, X.-J. Ruan, published in Eur Rev Med Pharmacol Sci 2018; 22 (17): 5525-5530-DOI: 10.26355/eurrev_201809_15813-PMID: 30229824, has been retracted in accordance with the Publisher and the Editor in Chief. Following a previously published Expression of Concern, the Editor-in-Chief and the Publisher have completed an investigation into the issues raised in relation to this article. The investigation confirmed concerns regarding non-verifiable nucleotide sequence reagents and the use of inadequately authenticated cell lines, which undermine the reliability of the findings reported. The authors did not respond to correspondence regarding these concerns. The Editor-in-Chief and the Publisher have therefore decided to retract this article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause.</p>","PeriodicalId":12152,"journal":{"name":"European review for medical and pharmacological sciences","volume":"30 3","pages":"94"},"PeriodicalIF":3.3000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Retraction Note: Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.\",\"authors\":\"Y-X Shi, B-L Ye, B-R Hu, X-J Ruan\",\"doi\":\"10.26355/eurrev_202603_37717\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The article \\\"Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer\\\" by Y.-X. Shi, B.-L. Ye, B.-R. Hu, X.-J. Ruan, published in Eur Rev Med Pharmacol Sci 2018; 22 (17): 5525-5530-DOI: 10.26355/eurrev_201809_15813-PMID: 30229824, has been retracted in accordance with the Publisher and the Editor in Chief. Following a previously published Expression of Concern, the Editor-in-Chief and the Publisher have completed an investigation into the issues raised in relation to this article. The investigation confirmed concerns regarding non-verifiable nucleotide sequence reagents and the use of inadequately authenticated cell lines, which undermine the reliability of the findings reported. The authors did not respond to correspondence regarding these concerns. The Editor-in-Chief and the Publisher have therefore decided to retract this article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause.</p>\",\"PeriodicalId\":12152,\"journal\":{\"name\":\"European review for medical and pharmacological sciences\",\"volume\":\"30 3\",\"pages\":\"94\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2026-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European review for medical and pharmacological sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.26355/eurrev_202603_37717\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European review for medical and pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.26355/eurrev_202603_37717","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
y - x的文章“miR-1294表达下调,预示胃癌预后不良”。施,B.-L。你们B.-R。胡,X.-J。Ruan,发表于Eur Rev Med Pharmacol Sci 2018;22 (17): 5525-5530-DOI: 10.26355/eurrev_201809_15813-PMID: 30229824,已根据出版商和主编的要求撤回。根据之前发表的关注表达,总编辑和出版商已经完成了对与本文有关的问题的调查。调查证实了对无法验证的核苷酸序列试剂和使用未经充分验证的细胞系的担忧,这破坏了报告结果的可靠性。作者没有答复关于这些关切的信件。总编辑和出版人因此决定撤回这篇文章。这篇文章已被撤回。对于由此造成的任何不便,出版商深表歉意。
Retraction Note: Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.
The article "Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer" by Y.-X. Shi, B.-L. Ye, B.-R. Hu, X.-J. Ruan, published in Eur Rev Med Pharmacol Sci 2018; 22 (17): 5525-5530-DOI: 10.26355/eurrev_201809_15813-PMID: 30229824, has been retracted in accordance with the Publisher and the Editor in Chief. Following a previously published Expression of Concern, the Editor-in-Chief and the Publisher have completed an investigation into the issues raised in relation to this article. The investigation confirmed concerns regarding non-verifiable nucleotide sequence reagents and the use of inadequately authenticated cell lines, which undermine the reliability of the findings reported. The authors did not respond to correspondence regarding these concerns. The Editor-in-Chief and the Publisher have therefore decided to retract this article. This article has been retracted. The Publisher apologizes for any inconvenience this may cause.
期刊介绍:
European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research.
The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine.
European Review for Medical and Pharmacological Sciences includes:
-Editorials-
Reviews-
Original articles-
Trials-
Brief communications-
Case reports (only if of particular interest and accompanied by a short review)